INSL5 | Insulin-like 5 | Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/30100/140637_B_1_8_rna_selected_60x60.jpg) | Group enriched |
AQP8 | Aquaporin 8 | Predicted membrane proteins Transporters
| ![](/images/46259/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/46259/147427_B_6_8_rna_selected_60x60.jpg) | Group enriched |
HOXB13 | Homeobox B13 | Transcription factors
| | | | ![](/images/4438/19508_B_9_3_rna_selected_60x60.jpg) | Group enriched |
ISX | Intestine-specific homeobox | Transcription factors
| ![](/images/60328/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/60328/138009_B_8_2_rna_selected_60x60.jpg) | Group enriched |
MEP1A | Meprin A, alpha (PABA peptide hydrolase) | Enzymes Plasma proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/25163/57017_B_8_2_rna_selected_60x60.jpg) | Group enriched |
CA1 | Carbonic anhydrase I | Enzymes FDA approved drug targets Plasma proteins
| | ![](/images_static/na_center.gif) | | ![](/images/6558/22094_B_9_1_rna_selected_60x60.jpg) | Group enriched |
PRAC1 | Prostate cancer susceptibility candidate 1 | | ![](/images/47871/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/47871/110175_B_8_2_rna_selected_60x60.jpg) | Group enriched |
TMIGD1 | Transmembrane and immunoglobulin domain containing 1 | Predicted membrane proteins Predicted secreted proteins
| ![](/images/21946/ihc_selected_60x60.jpg) | ![](/images/21946/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/21946/50852_B_9_8_rna_selected_60x60.jpg) | Group enriched |
BTNL3 | Butyrophilin-like 3 | Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
CHP2 | Calcineurin-like EF-hand protein 2 | Cancer-related genes
| ![](/images/72806/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/72806/153331_B_8_2_rna_selected_60x60.jpg) | Group enriched |
GUCA2B | Guanylate cyclase activator 2B (uroguanylin) | Plasma proteins Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
NOX1 | NADPH oxidase 1 | Plasma proteins Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/35299/74796_A_5_3_rna_selected_60x60.jpg) | Group enriched |
KRTAP13-2 | Keratin associated protein 13-2 | Plasma proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
MS4A12 | Membrane-spanning 4-domains, subfamily A, member 12 | Predicted membrane proteins
| ![](/images/57657/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images/57657/ihc_cell_selected_60x60.jpg) | ![](/images/57657/129995_A_2_2_rna_selected_60x60.jpg) | Group enriched |
SLC39A5 | Solute carrier family 39 (zinc transporter), member 5 | Predicted membrane proteins Predicted secreted proteins Transporters
| ![](/images/18423/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/18423/43605_B_9_2_rna_selected_60x60.jpg) | Group enriched |
TBX10 | T-box 10 | Predicted secreted proteins Transcription factors
| ![](/images/47881/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/47881/109018_B_8_3_rna_selected_60x60.jpg) | Group enriched |
GUCY2C | Guanylate cyclase 2C (heat stable enterotoxin receptor) | Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins
| ![](/images/37655/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/37655/78313_B_8_5_rna_selected_60x60.jpg) | Group enriched |
LRRC26 | Leucine rich repeat containing 26 | Cytoskeleton related proteins Predicted membrane proteins
| ![](/images/56312/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/56312/129077_B_8_2_rna_selected_60x60.jpg) | Group enriched |
MOGAT2 | Monoacylglycerol O-acyltransferase 2 | Enzymes Predicted membrane proteins
| ![](/images/28834/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/28834/60966_B_9_2_rna_selected_60x60.jpg) | Group enriched |
TUBAL3 | Tubulin, alpha-like 3 | | ![](/images/63394/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/45900/103120_B_8_2_rna_selected_60x60.jpg) | Group enriched |
MUC12 | Mucin 12, cell surface associated | Predicted membrane proteins
| | ![](/images/27769/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/23835/151376_B_7_1_rna_selected_60x60.jpg) | Group enriched |
NAT2 | N-acetyltransferase 2 (arylamine N-acetyltransferase) | Cancer-related genes Enzymes
| ![](/images/43704/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/43704/107893_B_7_8_rna_selected_60x60.jpg) | Group enriched |
GLRA2 | Glycine receptor, alpha 2 | FDA approved drug targets Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images/53525/ihc_cell_selected_60x60.jpg) | ![](/images/53525/135622_A_2_5_rna_selected_60x60.jpg) | Group enriched |
GAL3ST2 | Galactose-3-O-sulfotransferase 2 | Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
ATOH1 | Atonal homolog 1 (Drosophila) | Cancer-related genes Plasma proteins Transcription factors
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
GUCA2A | Guanylate cyclase activator 2A (guanylin) | Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/18215/ihc_cell_selected_60x60.jpg) | ![](/images/18215/141725_B_8_1_rna_selected_60x60.jpg) | Group enriched |
PYY | Peptide YY | Predicted secreted proteins
| | | ![](/images/16734/ihc_cell_selected_60x60.jpg) | ![](/images/10973/51810_A_1_6_rna_selected_60x60.jpg) | Group enriched |
TMEM236 | | Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
NXPE1 | Neurexophilin and PC-esterase domain family, member 1 | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/49133/151422_B_8_3_rna_selected_60x60.jpg) | Group enriched |
REP15 | RAB15 effector protein | | ![](/images/40448/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/40448/87960_B_8_1_rna_selected_60x60.jpg) | Group enriched |
RP11-77K12.7 | | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
TMEM82 | Transmembrane protein 82 | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/60282/ihc_cell_selected_60x60.jpg) | ![](/images/60282/134282_B_8_3_rna_selected_60x60.jpg) | Group enriched |
CEACAM5 | Carcinoembryonic antigen-related cell adhesion molecule 5 | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/21/18_B_7_1_rna_selected_60x60.jpg) | Group enriched |
CHST5 | Carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 5 | Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/43804/96382_B_8_5_rna_selected_60x60.jpg) | Group enriched |
DHRS11 | Dehydrogenase/reductase (SDR family) member 11 | | | ![](/images/41226/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/48236/113656_B_8_3_rna_selected_60x60.jpg) | Group enriched |
NXPE4 | Neurexophilin and PC-esterase domain family, member 4 | Predicted secreted proteins
| ![](/images/42801/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/42801/95106_B_8_1_rna_selected_60x60.jpg) | Group enriched |
TMEM236 | Transmembrane protein 236 | Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
UGT1A10 | UDP glucuronosyltransferase 1 family, polypeptide A10 | Cancer-related genes Enzymes Predicted membrane proteins Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
VIL1 | Villin 1 | Cancer-related genes Disease related genes Plasma proteins
| | | | ![](/images/2452/6277_B_7_7_rna_selected_60x60.jpg) | Group enriched |
AOC1 | Amine oxidase, copper containing 1 | Enzymes Predicted secreted proteins
| | ![](/images/31032/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/31033/72999_A_3_5_rna_selected_60x60.jpg) | Group enriched |
BEST2 | Bestrophin 2 | Predicted membrane proteins Transporters
| ![](/images/46229/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images/46229/ihc_cell_selected_60x60.jpg) | ![](/images/46229/104976_B_9_1_rna_selected_60x60.jpg) | Group enriched |
C10orf99 | Chromosome 10 open reading frame 99 | Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/50920/117820_B_8_4_rna_selected_60x60.jpg) | Group enriched |
CDX1 | Caudal type homeobox 1 | Transcription factors
| | ![](/images_static/na_center.gif) | ![](/images/55196/ihc_cell_selected_60x60.jpg) | ![](/images/55196/127987_B_9_1_rna_selected_60x60.jpg) | Group enriched |
HHLA2 | HERV-H LTR-associating 2 | Predicted membrane proteins Predicted secreted proteins
| ![](/images/29417/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/29417/61299_B_9_2_rna_selected_60x60.jpg) | Group enriched |
HOXA13 | Homeobox A13 | Cancer-related genes Disease related genes Transcription factors
| ![](/images_static/rna_center.gif) | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
HOXD11 | Homeobox D11 | Cancer-related genes Transcription factors
| ![](/images_static/rna_center.gif) | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
LYPD8 | LY6/PLAUR domain containing 8 | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
NR1I2 | Nuclear receptor subfamily 1, group I, member 2 | FDA approved drug targets Nuclear receptors Plasma proteins Transcription factors
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
TPH1 | Tryptophan hydroxylase 1 | Enzymes FDA approved drug targets
| | ![](/images/22483/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/10767/28958_B_2_1_rna_selected_60x60.jpg) | Group enriched |
TPSG1 | Tryptase gamma 1 | Enzymes Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/60458/135089_B_5_5_rna_selected_60x60.jpg) | Group enriched |